Picture of Prestige Consumer Healthcare logo

PBH — Prestige Consumer Healthcare News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Prestige Consumer Healthcare Inc reports results for the quarter ended June 30 - Earnings Summary

Prestige Consumer Healthcare Inc PBH.N reported quarterly adjusted earnings of 95 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 90 cents.  The mean expectation of seven analysts for the quarter was for earnings of $1.00 per share. Wall Street expected results to range from 98 cents to $1.04 per share.

Revenue fell 6.6% to $249.53 million from a year ago; analysts expected $261.01 million.

Prestige Consumer Healthcare Inc's reported EPS for the quarter was 95 cents​.

Prestige Consumer Healthcare Inc shares had fallen by 5.9% this quarter and lost 3.8% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 1.8% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

Wall Street's median 12-month price target for Prestige Consumer Healthcare Inc is $90.00, about 16.5% above its last closing price of $75.16

This summary was machine generated from LSEG data August 7 at 03:47 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
Jun. 30 20251.000.95Missed
Mar. 31 20251.301.32Beat
Dec. 31 20241.161.22Beat
Sep. 30 20241.081.09Beat

Recent news on Prestige Consumer Healthcare

See all news